Literature DB >> 18262181

Choroidal microcirculation in Abyssinian cats with hereditary rod-cone degeneration.

Christian-Albrecht May1, Kristina Narfström.   

Abstract

Blood flow in the choroid of eyes with retinal degeneration is normally reduced. In the Abyssinian cat, where no changes in choroidal blood flow were observed recently, a closer morphological analysis revealed that two factors might have lead to this finding. (a) The cat's eye consists of a tapetum lucidum where 15.5 microm microspheres cannot reach the precapillary branching in contrast to the non-tapetal areas, where microspheres were located right next to the choriocapillaris. This fact has not yet been described and might be important for further physiological measurements in eyes of species with a tapetum lucidum. (b) The tapetal cells themselves might have a protective role for the choriocapillaris and RPE during retinal degeneration in this specific animal model. Even in late stages of retinal degeneration the RPE and choriocapillaris in areas covered by the tapetum lucidum were not affected whereas non-tapetal areas showed loss of RPE and capillaries.

Entities:  

Mesh:

Year:  2008        PMID: 18262181     DOI: 10.1016/j.exer.2007.12.011

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  3 in total

Review 1.  Genetic, environmental and other risk factors for progression of retinitis pigmentosa.

Authors:  Zi-Yang Huang; Li-Na Liang; Ya-Min Li; Kai Xu; Xiao-Yu Li
Journal:  Int J Ophthalmol       Date:  2022-05-18       Impact factor: 1.645

2.  Decreased retinal-choroidal blood flow in retinitis pigmentosa as measured by MRI.

Authors:  Yi Zhang; Joseph M Harrison; Oscar San Emeterio Nateras; Steven Chalfin; Timothy Q Duong
Journal:  Doc Ophthalmol       Date:  2013-02-14       Impact factor: 2.379

3.  Choroidal Thickness Analysis in Patients with Usher Syndrome Type 2 Using EDI OCT.

Authors:  L Colombo; B Sala; G Montesano; C Pierrottet; S De Cillà; P Maltese; M Bertelli; L Rossetti
Journal:  J Ophthalmol       Date:  2015-05-17       Impact factor: 1.909

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.